Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
Abstract Background Nonsteroidal anti‐inflammatory drug (NSAID) exacerbated respiratory disease (N‐ERD) is a triad with asthma, chronic rhinosinusitis with nasal polyps, and NSAID intolerance. Uncontrolled N‐ERD forms a major public health problem due to frequent and difficult‐to‐treat exacerbations...
Saved in:
| Main Authors: | Annina Lyly, Anu Laulajainen‐Hongisto, Heikki Turpeinen, Seija I. Vento, Jyri Myller, Jura Numminen, Saara Sillanpää, Johanna Sahlman, Paula Kauppi, Sanna Toppila‐Salmi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-03-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.347 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma
by: Sanna Toppila-Salmi, et al.
Published: (2025-05-01) -
Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma
by: Annina Lyly, et al.
Published: (2025-03-01) -
Radiological score, asthma and NSAID‐exacerbated respiratory disease predict relapsing chronic rhinosinusitis
by: Markus Lilja, et al.
Published: (2025-04-01) -
Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study
by: Tina Bartosik, et al.
Published: (2025-05-01) -
ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care
by: D. M. Conti, et al.
Published: (2025-06-01)